about
Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens.Signature-tagged mutagenesis in a chicken infection model leads to the identification of a novel avian pathogenic Escherichia coli fimbrial adhesinNERVE: new enhanced reverse vaccinology environmentFimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling.Adhesive threads of extraintestinal pathogenic Escherichia coli.FungalRV: adhesin prediction and immunoinformatics portal for human fungal pathogens.Vaccines for mucosal immunity to combat emerging infectious diseases.Search for potential vaccine candidate open reading frames in the Bacillus anthracis virulence plasmid pXO1: in silico and in vitro screening.An adhesion protein of Salmonella enterica serovar Typhi is required for pathogenesis and potential target for vaccine development.Medical biofilms.Jenner-predict server: prediction of protein vaccine candidates (PVCs) in bacteria based on host-pathogen interactions.Pneumolysin-dependent and -independent gene expression identified by cDNA microarray analysis of THP-1 human mononuclear cells stimulated by Streptococcus pneumoniaeMapping the binding domain of the F18 fimbrial adhesin.Immune responses induced by replication-defective adenovirus expressing the C-terminal portion of the Mycoplasma hyopneumoniae P97 adhesin.Detection of lytA, pspC, and rrgA genes in Streptococcus pneumoniae isolated from healthy childrenDrug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.Targeting the bacteria-host interface: strategies in anti-adhesion therapy.Receptor binding domain of Escherichia coli F18 fimbrial adhesin FedF can be both efficiently secreted and surface displayed in a functional form in Lactococcus lactis.Effectiveness of F18+ Fimbrial Antigens Released by a Novel Autolyzed Salmonella Expression System as a Vaccine Candidate against Lethal F18+ STEC Infection.Intranasal vaccination with streptococcal fibronectin binding protein Sfb1 fails to prevent growth and dissemination of Streptococcus pyogenes in a murine skin infection model.Anti-adhesion methods as novel therapeutics for bacterial infections.Characterization of the heparin-binding site of the mycobacterial heparin-binding hemagglutinin adhesin.Selection of Vaccine Candidates for Fish Pasteurellosis Using Reverse Vaccinology and an In Vitro Screening Approach.Identification and characterization of merozoite surface protein 1 epitopeAdherence of Burkholderia pseudomallei cells to cultured human epithelial cell lines is regulated by growth temperature.Mice lacking T and B lymphocytes develop transient colitis and crypt hyperplasia yet suffer impaired bacterial clearance during Citrobacter rodentium infection.Identification of Salmonella enteritidis outer membrane proteins expressed during attachment to human intestinal epithelial cells.Cluster analysis identifies aminoacid compositional features that indicate Toxoplasma gondii adhesin proteins.Comparative analysis of the complete genome of KPC-2-producing Klebsiella pneumoniae Kp13 reveals remarkable genome plasticity and a wide repertoire of virulence and resistance mechanisms.Role of StdA in adhesion of Salmonella enterica serovar Enteritidis phage type 8 to host intestinal epithelial cells.MalVac: database of malarial vaccine candidates.Role of the flagellar basal-body protein, FlgC, in the binding of Salmonella enterica serovar Enteritidis to host cells.flp-1, the first representative of a new pilin gene subfamily, is required for non-specific adherence of Actinobacillus actinomycetemcomitans.Carboxyl terminus heterogeneity of type IV fimbrial subunit protein of Pasteurella multocida isolates.SPAAN: a software program for prediction of adhesins and adhesin-like proteins using neural networks.Differential activation of the immune system by virulent Streptococcus pneumoniae strains determines recovery or death of the host.Intranasal immunization with a recombinant truncated FimH adhesin adjuvanted with CpG oligodeoxynucleotides protects mice against uropathogenic Escherichia coli challenge.Characteristics of bacterial biofilm associated with implant material in clinical practiceMolecular Evolution of Rickettsia Surface Antigens: Evidence of Positive Selection
P2860
Q30783500-750729EF-3DAD-46F3-BBE6-475076699AD1Q30882970-28482991-AC08-4C7A-A7D6-7585D30B7125Q33250601-D758EA79-BABA-45DA-A24B-8B7330B35B9CQ33389846-660DCD25-73A7-4C73-A60A-B0B29193C6D2Q33554744-35B56A4C-8F1A-4F16-840B-A6CC7846EF0DQ33874270-189D34AF-01ED-45D2-93C9-03C95C9B4A6EQ33886205-3AF6A77A-6214-4F88-B981-23D6BAD5FF4CQ34262140-50412138-2D40-442C-9BAB-92B2D0B30886Q34602404-F350E9EA-5E35-40FE-AF5E-D71FA8883D6EQ34764576-6C3C74FF-36C5-4D0D-B367-2B44F0D10B0BQ34787708-42CEB99B-7C03-4791-857C-1F66FAC10186Q34852939-77047B8E-9DCD-435E-8416-8B1A8856D57AQ34854361-7618C2D8-F2C2-4637-8C09-2B2BD6EE5175Q35946937-BB74C84D-74E7-47FE-8A76-2AE4458A4336Q36366411-BC83B43F-855B-48B7-80DD-FBE3B82B7A2FQ36951570-9158D3F3-CF65-44A9-81B5-7AFC53219601Q37009022-575AF9A7-1504-4459-A8E6-908FC6AAEEB3Q37318511-82BD7C21-69F4-457D-A39D-8A2105C462C9Q37427473-9C7EFB4F-43C1-47FD-A3FC-8080A84BA094Q37623644-D7470E99-5646-42E8-827A-27E115EEF7D7Q38068610-62A6AA2F-14F9-461C-BE6A-5A0C76739DD3Q38312566-7CA80F2F-431A-4527-A2F8-20FCDCF3ED70Q38778395-27258FF2-B474-422E-86CA-B5E453FCEBC8Q39467736-CE2731D3-92D3-4C84-AEC1-BEEF8718CCAEQ39653766-A7E5CE7A-AD0F-44E3-821B-17A595FB74A3Q39654380-7B80DA87-D3B3-4182-9A94-D96BC9D5596EQ40750569-4E910B01-DC34-4D93-8E5D-D07530F00EC2Q41501354-F86D2F62-F306-4477-8C03-EB06426AA271Q41824709-D0B73957-DB1E-4A05-AE5E-F44730935BEBQ41845475-911BC20D-4FE5-4D9E-AA75-965515F47294Q42098879-E6A36725-92D0-4183-9022-0DEE63BAE4A9Q42452407-B155EECF-41FF-4423-9C48-1AE48659DAB2Q42649650-53FC24B2-8EDA-4D94-9AB2-7F88ED150E2FQ43710521-7E94DF95-75D5-4DD7-BC24-48C1E2569A6AQ47925565-FDCD4666-FA4F-4EAA-9DC5-7A5EE9384201Q51190254-72D0348B-CE66-4861-A1DC-3F737136807EQ54448728-393D83FC-877D-462B-BE58-77FA08E9EB7AQ56115840-3C4A8889-6856-4844-8738-EDD1120893DBQ57986015-06C33BC8-5C4F-4106-9482-970FF80F60BF
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Adhesins as targets for vaccine development.
@ast
Adhesins as targets for vaccine development.
@en
type
label
Adhesins as targets for vaccine development.
@ast
Adhesins as targets for vaccine development.
@en
prefLabel
Adhesins as targets for vaccine development.
@ast
Adhesins as targets for vaccine development.
@en
P2093
P2860
P356
P1476
Adhesins as targets for vaccine development.
@en
P2093
Langermann S
Wizemann TM
P2860
P304
P356
10.3201/EID0503.990310
P577
1999-05-01T00:00:00Z